This research review advocates for a high-dose, statin-first approach to managing cardiovascular disease and reevaluates the more limited role of popular adjunctive therapies, such as ezetimibe and evolocumab.
Most Recent Articles
A Statin-First Strategy: Prioritizing High-Potency Statins in Cardiovascular Disease Management
This research review advocates for a high-dose, statin-first approach to managing cardiovascular disease and reevaluates the more limited role of popular adjunctive therapies, such as ezetimibe and evolocumab.
Reevaluating Pulmonary Impairment: De-implementing Race in Disability Compensation Guidelines
A multi-institutional team outlines critical next steps to ensure the move toward race-neutral lung function testing results in more equitable disability and workers' compensation evaluations.
Predicting Systemic Inflammation from VRTIs Using Wearable Sensors and Machine Learning
New research shows that AI analyzing data from your smart ring can detect a viral infection before you even feel unwell, outperforming traditional symptom-tracking methods.
A Validated 4-Gene Signature Predicts Immunotherapy Failure and Survival in Melanoma
A novel four-gene signature can predict with high accuracy which melanoma patients are unlikely to respond to immunotherapy, paving the way for personalized treatment.